Chronic heart failure with reduced EF: a decade of major pharmacological innovations

CONCLUSION: The results of the clinical trials reviewed here represent major advances that will have a significant impact on quality of life, survival, rehospitalisation and, for certain treatments, a beneficial joint effect on commonly associated comorbidities such as diabetes and chronic renal failure.PMID:38072123 | DOI:10.1016/j.lpm.2023.104219
Source: Presse Medicale - Category: General Medicine Authors: Source Type: research